FDA-Drug2026-03-11Class IICHEMICAL
Teva metoprolol succinate 200 mg tablets recalled for failed dissolution
OTHERNationwide distribution
Stop using Teva metoprolol succinate 200 mg tablets
Teva Pharmaceuticals is recalling specific lots of metoprolol succinate extended-release 200 mg tablets because they failed to meet dissolution specifications—meaning the tablets may not break down and release the medication properly in your body. This could affect how well the blood pressure medication works. No injuries have been reported.
- Check if your metoprolol succinate 200 mg bottle matches lot numbers 0686H251, 0687H251, or 10688H251 with expiration 02/2027 (NDC 45963-678-11)
- If you have an affected bottle, contact your pharmacy or doctor before stopping the medication
- Do not stop taking your blood pressure medication without medical guidance
- Return the recalled bottle to your pharmacy
Hazard
Failed Dissolution Specifications
Sold states
Nationwide
Affected count
19,056 bottles
Manufactured in
400 Interpace Pkwy Bldg A, N/A, Parsippany, NJ, United States
Products
Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054, NDC: 45963-678-11
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0357-2026More Teva Pharmaceuticals USA, Inc recalls
- FDA-Drug2026-04-29Teva Claravis (isotretinoin) 10 mg recalled for elevated tretinoin impurity levels
- FDA-Drug2026-04-15Teva Clonidine Transdermal System 0.2 mg/day recalled for unapproved raw material
- FDA-Drug2026-04-15Teva Clonidine Transdermal System 0.1 mg recalled for unapproved raw material
- FDA-Drug2026-04-15Teva Clonidine Transdermal System 0.3 mg recalled for unapproved raw material
- FDA-Drug2026-04-15Teva Isotretinoin 40 mg capsules recalled for inconsistent strength
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief